Targeting ER stress/IRE1α has thus been proposed for its potential in countering obesity and obesity-related metabolic disorders including insulin resistance and type 2 diabetes (Hetz, Chevet et al. 2013, Marciniak, Chambers et al. 2021). The gene discussed is ERN1; the disease is metabolic disease.